Evaluating outcomes of cancer and benign disease patients treated with radiation
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation at the University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center · NCT03617237
This study is trying to gather information from patients who have received radiation treatment for cancer or non-cancer conditions to see how well it worked and how it affected their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | University of Texas Southwestern Medical Center (other) |
| Drugs / interventions | radiation, chemotherapy |
| Locations | 1 site (Dallas, Texas) |
| Trial ID | NCT03617237 on ClinicalTrials.gov |
What this trial studies
This observational study aims to create a registry database to assess the clinical outcomes of patients who have received or been evaluated for radiation treatment for both cancer and benign conditions. The study will retrospectively collect comprehensive data, including medical history, treatment details, and quality of life outcomes, from patients treated since 2000. The goal is to compare these outcomes with the National Cancer Data Base to enhance future clinical practices and identify areas for prospective studies.
Who should consider this trial
Good fit: Ideal candidates include patients who have received or been evaluated for radiation therapy for benign or malignant conditions since 2000.
Not a fit: Patients who have not undergone radiation therapy and are receiving alternative treatments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies and outcomes for patients undergoing radiation therapy.
How similar studies have performed: Other studies have shown success in utilizing registry data to improve clinical outcomes, making this approach both relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Any patient who received or was potentially evaluated for radiotherapy since 2000 for benign or malignant etiologies in the definitive or palliative setting. Patients with comparatively similar diagnosis and disease status at UTSW, but electing not to undergo radiation therapy, treated with surgical or systemic therapy, or best supportive care, being followed by an oncology specialist at UT Southwestern Medical Center will also be eligible for evaluation. - Exclusion Criteria: None
Where this trial is running
Dallas, Texas
- UT Southwestern Medical Centre — Dallas, Texas, United States (RECRUITING)
Study contacts
- Principal investigator: David J Sher, MD, MPH — University of Texas Southwestern Medical Center
- Study coordinator: Sarah Neufeld, MS
- Email: sarah.hardee@utsouthwestern.edu
- Phone: 2146458525
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer